BioPharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Farmers Insurance
Argus Health
Express Scripts

Generated: November 21, 2017

DrugPatentWatch Database Preview

Details for Patent: 5,952,323

« Back to Dashboard

Which drugs does patent 5,952,323 protect, and when does it expire?

Patent 5,952,323 protects INVANZ and is included in one NDA. There has been one Paragraph IV challenge on Invanz.

Protection for INVANZ has been extended six months for pediatric studies, as indicated by the *PED designation in the table below.

This patent has fifty patent family members in forty countries.

Summary for Patent: 5,952,323

Title: Carbapenem antibiotic
Abstract:A pharmaceutical composition is disclosed which contains a compound of formula I: ##STR1## or a pharmaceutically acceptable salt, prodrug or hydrate thereof, in the stabilized form and/or in combination with a carbon dioxide source.
Inventor(s): Zimmerman; Jeffrey A. (Chalfont, PA), Williams; John M. (Belle Mead, NJ), Bergquist; Paul A. (Collegeville, PA), DiMichele; Lisa M. (Berkeley Heights, NJ), DuBost; David C. (Collegeville, PA), Kaufman; Michael J. (New Hope, PA), Sidler; Daniel R. (Whitehouse Station, NJ), Hunke; William A. (Harleysville, PA)
Assignee: Merck & Co., Inc. (Rahway, NJ)
Application Number:09/064,426
Patent Claim Types:
see list of patent claims
Compound; Composition; Use;

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use
Merck Sharp Dohme
ertapenem sodium
INJECTABLE;INTRAMUSCULAR, IV (INFUSION)021337-001Nov 21, 2001RXYesYes► Subscribe► SubscribeY
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

International Patent Family for Patent: 5,952,323

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
European Patent Office0863901► SubscribePA2004008,C0863901Lithuania► Subscribe
European Patent Office0863901► SubscribePA2004008Lithuania► Subscribe
European Patent Office0863901► SubscribeC00863901/01Switzerland► Subscribe
Spain2208907► Subscribe
Norway980380► Subscribe
Mexico9800808► Subscribe
JapanH11509871► Subscribe
South Korea100403497► Subscribe
Japan5255983► Subscribe
Japan2009084284► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Daiichi Sankyo
US Army
Cantor Fitzgerald

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

Google Plus